Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life

NCT01278498 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01278498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
December 31, 2015
Enrollment
444 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

depression